Market Analysis: Page 10

What's next in cancer imaging?

By Bob Jacobus

It's time for radiology to deliver a higher level of cancer imaging for oncologists, according to Bob Jacobus, CEO of software developer AI Metrics. In a new column, he discusses key challenges and potential solutions.

January 22, 2023

Education is the catalyst to increased adoption of handheld ultrasound

By Mustafa Hassan

Handheld ultrasound has not yet reached mainstream adoption, but the worldwide market is still projected to reach over $500 million by 2026, according to Signify Research's newly published Handheld Ultrasound Deep Dive Report 2022.

January 19, 2023

IMV: Mammography departments expect budgets to grow by nearly 10%

By Davin Korstjens

Mammography departments are anticipating that their current budgets will grow by an estimated 9.7% per year from 2023 through 2025, according to IMV Medical Information Division's 2022 Mammography and Breast Imaging Market Outlook Report.

January 18, 2023

IMV: MR departments optimistic on procedure volume growth, purchasing

By Davin Korstjens

Three-quarters of MR sites in the U.S. anticipate that their 2022 procedure volume will be higher in 2022 than in 2021, according to IMV Medical Information Division's 2022 MR Market Outlook Report. And that growth will be achieved across all site types.

January 12, 2023

RSNA 2022: Predictions vs. reality

By Steve Holloway

Much has already been written about attendance at RSNA, but from a firsthand perspective, RSNA 2022 could be regarded as a step back toward "normal." Among mostly bustling halls, vendors reported very positive feedback on the volume and quality of customer meetings, with one prominent global imaging vendor citing "We're signing deals here at the show again -- things are looking up."

December 13, 2022

The 2022 PACSman Awards: The RSNA and WWII

By Michael J. Cannavo

Imaging industry consultant Michael J. Cannavo, aka the PACSman, may not have made it to Chicago this year for RSNA 2022. Fortunately, he was still able to produce his popular PACSman awards for the meeting.

November 30, 2022

Video from RSNA 2022: Gadopiclenol emerges as gadolinium-based contrast agent

CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about its potential, we spoke with Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.

November 30, 2022

Video from RSNA 2022: AI implementation trends

CHICAGO - What is the current state of radiology artificial intelligence (AI) in radiology? Dr. Peter Chang of the University of California, Irvine shared his perspective in a video interview at RSNA 2022.

November 29, 2022

Imaging leaders call for focus on patient outcomes

By Amerigo Allegretto

CHICAGO - Patient care and outcomes are central to radiology despite advances in imaging. This was the overall takeaway from the opening plenary session held November 27 at the RSNA annual meeting in Chicago.

November 27, 2022

The PACSMan Pontificates: RSNA 2022 -- Should I stay or should I go?

By Michael J. Cannavo

Imaging industry consultant Michael J. Cannavo, aka the PACSman, is attending RSNA 2022 virtually this year. He shares his thoughts on the pros and cons of virtual versus in-person attendance.

November 26, 2022

AI, photon-counting CT will figure prominently at RSNA 2022

RSNA 2022 is just days away. What can attendees expect from this year's meeting? AuntMinnie.com's Director of Content and Strategy Stephen Wellman offers a preview.

November 21, 2022

IMV: Dual-energy spectral imaging drives CT purchasing interest

By Davin Korstjens

Dual-energy spectral imaging CT systems are driving plans to purchase new CT scanners, according to a new report from IMV Medical Information Division. CT departments are also focusing on improving patient satisfaction.

November 15, 2022

Previous Page

Page 10 of 74

Next Page